Monterey Private Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,131
Closed -$263K 104
2022
Q4
$263K Sell
5,131
-331
-6% -$15.9K 0.14% 83
2022
Q3
$241K Sell
5,462
-710
-12% -$34.5K 0.14% 81
2022
Q2
$324K Buy
6,172
+871
+16% +$44.4K 0.19% 67
2022
Q1
$278K Buy
5,301
+16
+0.3% +$830 0.13% 89
2021
Q4
$312K Buy
+5,285
New +$262K 0.15% 81
2021
Q2
Sell
-5,640
Closed -$218K 100
2021
Q1
$218K Buy
5,640
+18
+0.3% +$639 0.12% 89
2020
Q4
$207K Sell
5,622
-393
-7% -$14.4K 0.12% 89
2020
Q3
$209K Buy
+6,015
New +$211K 0.13% 80
2020
Q2
Sell
-8,160
Closed -$253K 71
2020
Q1
$253K Sell
8,160
-997
-11% -$34K 0.22% 53
2019
Q4
$340K Buy
+9,157
New +$326K 0.27% 49

Other funds holding PFE

Monterey Private Wealth's PFE Position: Q1 2023 in Review

Monterey Private Wealth sold out of Pfizer (PFE) in Q1 2023, closing a stake of 5,131 shares — an estimated $263K sold.

Monterey Private Wealth first reported a position in PFE in Q4 2019 and held it in 10 quarters. The position peaked at $340K in Q4 2019. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Monterey Private Wealth reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • Monterey Private Wealth sold 5,131 Pfizer shares in Q1 2023, an estimated $263K.
  • Monterey Private Wealth first reported a position in Pfizer in Q4 2019 and held it in 10 quarters.
  • Monterey Private Wealth's Pfizer position peaked at $340K in Q4 2019.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Monterey Private Wealth's 13F filing for Q1 2023, filed 7 Apr 2023.